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Supplemental Figure 1
Supplemental Figure 1: Representative gating strategy for the FACS analysis of IL-22+ cells in the small 
























Supplemental Figure 2: Impact of Il-22 deficiency on intestinal epithelial cells of neonatal mice 
during NEC. Related to Figure 2. Representative confocal images of ileal tissue samples from WT and 
IL-22-/- were stained with an antibody against PCNA (Green). The nuclei were stained with Hoechst 
(Blue). Scale bar 50 µm. DF = Dam fed. 
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Supplemental Figure 3: IL-22 treatment does not protect against NEC in pups lacking the IL-22Ra1 in their intestinal 
epithelium. Related to Figure 3. Effect of IL-22 treatment on the intestinal expression of (A) Il1b, (B) Cxcl2 and (C) 
histological appearance of the terminal ileum sections from each genotype in the intestine of dam fed (DF) and pups 
subjected to NEC carrying a specific deletion of Il-22Ra1 in epithelial cells. All gene expression data are displayed as mean ±





























Supplemental Figure 4: Impact of Il-22 treatment on intestinal epithelial cell tight junctions during
NEC. Related to Figure 3. Representative confocal images of ileal tissue samples from wild-type dam fed (DF)
pups or pups with NEC treated with either PBS or recombinant IL-22 stained with an antibody against the tight
junction Occludin (Green) and Hoechst (Blue). Scale bar 50 µm.
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Supplemental Figure 5: Reg3g neutralization does not abrogate IL-22-mediated
protection against NEC. Related to Figure 5. DF pups and pups subjected to NEC received
a Reg3g neutralizing antibody or an isotype control (IgG) via oral gavage. Expression levels
of Il1b in the terminal ileum displayed as mean ± SEM were analyzed using Mann-Whitney






























































Supplemental Figure 6: Impact of IL-22 treatment on the relative abundance of Enterobacter,
Escherichia and Klebsiella bacterial species in the feces of pups subjected to experimental NEC.










Supplemental Figure 7: Representative histology of the small intestine after the induction of 
experimental NEC. Related to STAR Methods. The terminal ileum of newborn mice subjected to the 
experimental NEC protocol displays a phenotype ranging from normal to severe villi destruction. Scale 
bar 200 µm.
